AstraZeneca vaccine's success in early human trials bodes well for Adar Poonawalla and Serum Institute

Adar Poonawalla's Serum Institute of India is one of Astra Zeneca's partners in the search for the vaccine and will potentially be responsible for the mass manufacture of the final product.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news